Menlo Therapeutics OverviewMenlo Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for MNLO.
Quarterly EBIT
-$23.49M
↓ 39.35% YoY
As of Sep 30, 2020
Annual EBIT (TTM)
-$250.76M
↓ 259.26% YoY
Trailing 12 months ending Sep 30, 2020
Menlo Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for MNLO.
As of Sep 30, 2020
Trailing 12 months ending Sep 30, 2020